Skip to main content

Market Overview

Cara Therapeutics (NASDAQ: CARA)

12.50 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-0.35
9.266M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-0.62
8.093M



Q4 2020
After-Hours
EPS:
REV:
-0.61
4.511M
0.36
48.63M
1.59
112.089M
341.67%
130.49%
Q3 2020
After-Hours
EPS:
REV:
-0.74
5.785M
-0.60
4.77M
-0.35
9.266M
41.67%
94.26%
Q2 2020
After-Hours
EPS:
REV:
-0.58
5.208M
-0.67
5.06M
-0.54
5.634M
19.4%
11.34%
Q1 2020
After-Hours
EPS:
REV:
-0.56
4.382M
-0.62
4.76M
-0.62
8.093M
0%
70.02%
Q4 2019
After-Hours
EPS:
REV:
-0.52
5.533M
-0.66
4.79M
-0.61
4.511M
7.58%
-5.82%
Q3 2019
After-Hours
EPS:
REV:
-0.51
5.062M
-0.58
4.34M
-0.74
5.785M
-27.59%
33.29%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!